Catheter Precision, Inc. designs, manufactures, and sells medical technologies for cardiac electrophysiology (EP) in the United States and Europe. Its lead product is the View into Ventricular Onset System, a non-invasive imaging system that provides 3D cardiac mapping to help localize the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The company also offers LockeT, a suture retention device that temporarily secures sutures and aids clinicians in locating and removing them. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. and is based in Fort Mill, South Carolina.
Catheter Precision to Rebrand as Flyte Aviation, Adopt VJET Ticker
Catheter Precision announced Friday that its board of directors has approved changing the company's name to Flyte Aviation and its ticker symbol to VJET. The company will also effect a one-for-ten reverse stock split, as approved by stockholders at a special meeting on April 15, 2026. Every ten shares of common stock will be combined into one share, reducing outstanding shares from approximately 21.0 million to approximately 2.1 million, with no change to the par value or authorized shares. Shares will begin trading under the new name and ticker, on a split-adjusted basis, at the opening of trading on Monday, October 5, 2026.
Flyte Becomes Inaugural Enterprise Customer of Volato AI
Flyte, a subsidiary of Catheter Precision, has become the first enterprise customer of Volato AI, an artificial intelligence platform designed for business aviation. The deployment is part of Flyte's strategy to use advanced technology and automation to scale its regional private aviation platform, with expectations that Volato AI will enhance customer experience, improve operating efficiency, and increase workforce productivity across flight operations. The AI platform is expected to assist with operational workflows including customer communications, charter sales support, flight quoting, crew coordination, maintenance scheduling, dispatch support, compliance assistance, document management, and administrative processes. Flyte's CEO Marc Sellouk stated that intelligent automation will be critical for scaling operations efficiently while maintaining high customer service levels, and Volato Group's Chairman Matt Liotta noted that the partnership will help refine aviation-specific AI agents using real-world operating environments.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Demand
Aerospace & Aviation › Avionics & Aircraft Systems Technology
SOAR · Demand · Positive Volato AI secures its first enterprise customer, Flyte, validating its platform and generating revenue.
VTAK · Demand · Neutral Catheter Precision's subsidiary Flyte becomes Volato's customer, but impact on Catheter Precision is indirect and not detailed.
Flyte Partners with Blade to Expand Vision Jet Distribution
Flyte, the Regional Air Mobility subsidiary of Catheter Precision, has entered a strategic partnership with Blade Urban Air Mobility to feature its Cirrus Vision Jet fleet on Blade's platform. The agreement is expected to increase aircraft utilization, customer acquisition, brand awareness, and platform-driven revenue opportunities for Flyte by providing Blade passengers access to a modern, efficient, and cost-effective private aviation solution for regional travel. Flyte believes its Vision Jet fleet is uniquely positioned to complement Blade's customer base, which has historically focused on premium, time-sensitive regional travel solutions. The partnership is non-exclusive and subject to the terms and conditions of the parties' agreement.
VTAK · Demand · Positive Partnership with Blade expected to increase aircraft utilization and customer acquisition for Flyte, a subsidiary of Catheter Precision.
Blade Urban Air Mobility · Demand · Positive Blade gains access to Flyte's Vision Jet fleet, expanding its platform offerings for regional travel.
Flyte Partners With LifeVac To Equip Every Vision Jet With Life-Saving Device
Flyte, the regional air mobility subsidiary of Catheter Precision, announced a strategic partnership with LifeVac to equip its fleet of Cirrus Vision Jets with LifeVac's airway clearance device for choking emergencies. The partnership extends Flyte's safety program from the flight deck into the cabin, ensuring each aircraft is prepared for medical emergencies. LifeVac is the first and only suction anti-choking device to receive FDA De Novo authorization, cleared as a second-line treatment after standard choking-rescue protocols, and has been credited in more than 6,200 reported choking rescues worldwide. Placing LifeVac devices on every aircraft provides crews with an additional tool to respond to in-flight choking incidents where outside help is not available. Flyte's broader safety ecosystem integrates multiple layers of protection, including the Cirrus Airframe Parachute System, Safe Return Emergency Autoland technology, advanced Garmin flight deck systems, and a standardized fleet built entirely around the Vision Jet to reduce operational variables.
VTAK · Demand · Positive Flyte, a subsidiary of Catheter Precision, partners with LifeVac to equip its fleet, potentially increasing demand for LifeVac devices.
LifeVac LLC · Demand · Positive LifeVac secures a partnership to supply its airway clearance devices for Flyte's entire Vision Jet fleet, boosting sales.
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
Flyte, a subsidiary of Catheter Precision, announced continued operational growth following the launch of its enhanced digital booking platform, www.flyflyte.com. During the first six months of 2026, Flyte acquired more than 1,000 new platform users, facilitated 118 flights across its growing network, and generated more than $1.0 million in revenue. The platform allows customers to instantly price and book a Flyte Jet through a seamless digital experience, and is also designed to support aviation brokers, travel advisors, and strategic partners. Flyte exclusively operates a fleet of Cirrus Vision Jets, purpose-built for short-haul travel, offering access to thousands of private airports with jet-speed performance and industry-leading safety features. Founder and CEO Marc Sellouk stated that early results have been extremely encouraging, with strong growth from both direct bookings and an expanding network of broker and strategic partners.
Flyte partners with GSE Worldwide and PGA TOUR pro Emiliano Grillo at 2026 U.S. Open
Flyte, the regional air mobility subsidiary of Catheter Precision, announced a partnership with sports agency GSE Worldwide and PGA TOUR professional Emiliano Grillo that debuted at the 2026 U.S. Open. Grillo climbed as high as third place during the championship and finished tied for 23rd after a strong Saturday round of 3-under-par 67. The collaboration aims to showcase Flyte's fleet of Cirrus Vision Jets as a faster, more flexible travel option for elite athletes managing demanding regional schedules. CEO Marc Sellouk called the partnership a natural fit and the start of an expected long-term relationship with both GSE and Grillo. The deal positions Flyte within the professional sports ecosystem through one of the industry's premier talent agencies.
VTAK · Demand · Positive Flyte partnership with GSE Worldwide and PGA TOUR pro Grillo showcases its air mobility service to elite athletes, potentially driving customer demand.
United States